Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $23,000 | 2 | 99.3% |
| Food and Beverage | $167.87 | 3 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Smith+Nephew, Inc. | $23,000 | 2 | $0 (2020) |
| Incyte Corporation | $143.08 | 2 | $0 (2024) |
| Melinta Therapeutics, Inc. | $24.79 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26.17 | 1 | Incyte Corporation ($26.17) |
| 2023 | $116.91 | 1 | Incyte Corporation ($116.91) |
| 2020 | $11,500 | 1 | Smith+Nephew, Inc. ($11,500) |
| 2019 | $11,500 | 1 | Smith+Nephew, Inc. ($11,500) |
| 2018 | $24.79 | 1 | Melinta Therapeutics, Inc. ($24.79) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $26.17 | General |
| Category: Oncology | ||||||
| 10/12/2023 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $116.91 | General |
| Category: Oncology | ||||||
| 01/24/2020 | Smith+Nephew, Inc. | — | Education | Cash or cash equivalent | $11,500.00 | General |
| 05/14/2019 | Smith+Nephew, Inc. | — | Education | Cash or cash equivalent | $11,500.00 | General |
| 07/26/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: INFECTIOUS DISEASES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 782 | 936 | $250,418 | $110,642 |
| 2022 | 10 | 819 | 981 | $254,063 | $108,896 |
| 2021 | 9 | 671 | 803 | $182,709 | $76,149 |
| 2020 | 8 | 688 | 825 | $156,932 | $60,400 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 232 | 232 | $38,744 | $37,013 | 95.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 229 | 332 | $120,848 | $35,368 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 197 | $48,659 | $15,356 | 31.6% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2023 | 36 | 36 | $11,700 | $8,686 | 74.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 28 | $16,184 | $5,525 | 34.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 22 | 22 | $8,888 | $4,445 | 50.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 41 | 41 | $1,435 | $1,439 | 100.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 18 | 18 | $1,614 | $1,359 | 84.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 12 | $1,176 | $769.45 | 65.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $1,170 | $680.76 | 58.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 275 | 395 | $139,435 | $42,829 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 205 | 205 | $32,390 | $32,412 | 100.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 191 | 233 | $55,920 | $17,837 | 31.9% |
| 90671 | Pneumococcal conjugate vaccine, 15 valent (pcv15), for intramuscular use | Office | 2022 | 23 | 23 | $7,475 | $5,564 | 74.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $5,362 | $2,852 | 53.2% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 13 | $7,228 | $2,469 | 34.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 24 | 24 | $2,016 | $1,686 | 83.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 15 | $1,425 | $1,142 | 80.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $1,122 | $1,122 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 26 | $1,690 | $982.53 | 58.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 174 | 241 | $82,663 | $25,517 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 170 | 170 | $24,480 | $24,757 | 101.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 193 | 253 | $58,949 | $16,500 | 28.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 24 | 24 | $3,336 | $2,998 | 89.9% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 12 | 12 | $6,480 | $2,466 | 38.1% |
About Dr. Stephanie Wong, MD
Dr. Stephanie Wong, MD is a Internal Medicine healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396851663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephanie Wong, MD has received a total of $23,168 in payments from pharmaceutical and medical device companies, with $26.17 received in 2024. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Education" ($23,000).
As a Medicare-enrolled provider, Wong has provided services to 2,960 Medicare beneficiaries, totaling 3,545 services with total Medicare billing of $356,087. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mountain View, CA
- Active Since 08/21/2006
- Last Updated 12/02/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1396851663
Products in Payments
- MONJUVI (Drug) $143.08
- Baxdela (Drug) $24.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mountain View
Mr. Kenneth Peters, Md, MD
Internal Medicine — Payments: $111,214
Mr. Lawrence Epstein, Md, MD
Internal Medicine — Payments: $15,464
Sanjeev Tummala, Md, MD
Internal Medicine — Payments: $15,128
Joseph Chao, M.d, M.D
Internal Medicine — Payments: $14,752
Dr. Suneetha Maddineni, M.d, M.D
Internal Medicine — Payments: $13,762
Edward Huang, Md, Mph, MD, MPH
Internal Medicine — Payments: $9,951